PHARMA-TRADE A/S — Credit Rating and Financial Key Figures
CVR number: 87339815
Skaaremosevej 11-14, Blistrup 3230 Græsted
rsa@persano.dk
Income statement (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 334.73 | 366.15 | 337.74 | 374.75 | 382.24 |
| Other operating income | 0.00 | ||||
| Costs of manufacturing | - 274.80 | - 267.54 | |||
| Gross profit | 334.73 | 366.15 | 337.74 | 99.95 | 114.70 |
| Costs of management | -51.22 | -54.23 | |||
| Costs of distribution | -4.04 | -5.08 | |||
| EBIT | 55.61 | 59.52 | 36.67 | 44.69 | 55.38 |
| Other financial income | 1.16 | 1.73 | |||
| Other financial expenses | -1.80 | -1.78 | |||
| Reduction non-current investment assets | -0.21 | ||||
| Pre-tax profit | 41.08 | 46.44 | 28.02 | 43.85 | 55.34 |
| Income taxes | -9.49 | -12.20 | |||
| Net earnings | 41.08 | 46.44 | 28.02 | 34.35 | 43.14 |
Assets (mDKK)
2020 | 2021 | 2023 | 2024 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Land and waters | 69.07 | 75.02 | ||
| Buildings | 36.00 | 34.07 | ||
| Machinery and equipment | 1.92 | 1.94 | ||
| Advance payments and construction in progress | 2.64 | 5.01 | ||
| Tangible assets total | 109.63 | 116.04 | ||
| Investments total | 348.09 | 341.73 | 0.17 | -25.69 |
| Non-current loans receivable | 0.66 | 0.65 | ||
| Non-current other receivables | 0.06 | |||
| Long term receivables total | 0.73 | 0.65 | ||
| Semifinished products | 5.79 | 6.04 | ||
| Raw materials and consumables | 69.92 | 63.67 | ||
| Finished products/goods | 22.77 | 25.17 | ||
| Inventories total | 98.48 | 94.88 | ||
| Current trade debtors | 76.70 | 94.97 | ||
| Prepayments and accrued income | 1.27 | 0.16 | ||
| Current other receivables | 0.42 | 0.13 | ||
| Short term receivables total | 78.39 | 95.26 | ||
| Cash and bank deposits | 49.76 | 43.29 | ||
| Cash and cash equivalents | 49.76 | 43.29 | ||
| Balance sheet total (assets) | 348.09 | 341.73 | 337.16 | 324.43 |
Equity and liabilities (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 233.22 | 242.44 | 3.00 | 3.00 | |
| Asset revaluation reserve | 18.34 | 24.77 | |||
| Shares repurchased | 30.00 | 40.00 | |||
| Other reserves | 9.33 | -34.70 | |||
| Retained earnings | -41.08 | -46.44 | -28.02 | 156.35 | 161.88 |
| Profit of the financial year | 41.08 | 46.44 | 28.02 | 34.35 | 43.14 |
| Shareholders equity total | 233.22 | 242.44 | 251.38 | 238.09 | |
| Provisions | 14.50 | 16.72 | |||
| Non-current loans from credit institutions | 34.12 | 31.01 | |||
| Non-current deferred tax liabilities | 2.59 | ||||
| Non-current liabilities total | 36.71 | 31.01 | |||
| Current loans from credit institutions | 2.79 | 3.09 | |||
| Advances received | 0.24 | 0.36 | |||
| Current trade creditors | 28.77 | 20.45 | |||
| Short-term deferred tax liabilities | 0.26 | 0.21 | |||
| Other non-interest bearing current liabilities | 2.51 | 5.66 | |||
| Current liabilities total | 34.57 | 29.77 | |||
| Balance sheet total (liabilities) | 233.22 | 242.44 | 337.16 | 315.59 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.